Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine

Cancer

Volumn 75, Issue 7, 1995, Pages 1706-1711

  Marina, Neyssa M ^a   Greenwald, Carol A ^b,d   Diane L Fairclough, ^a   Thompson, Elizabeth I ^c   Wilimas, Judith A ^c   Mackert, Paul W ^c   Hudson, Melissa M ^d   Stokes, Dennis C ^d   Bozeman, Paula M ^d  

^a Department of Hematology Oncology Research Hospital ^*  (United States)

^b Research Hospital   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

combined modality therapy; Hodgkin's disease; pediatric; pulmonary function studies

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAS EXCHANGE; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION TEST; LUNG TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION INJURY; VITAL CAPACITY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; LUNG; MALE; VINBLASTINE;

EID: 0028932014     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950401)75:7<1706::AID-CNCR2820750723>3.0.CO;2-T     Document Type: Article

References (33)

1. Hodgkin's disease in children: treatment results with MOPP and low‐dose, extended‐field irradiation
2. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low‐dose regional radiation in advanced Hodgkin's disease in children: a report from the Children Cancer Study Group
3. Stage I‐II pediatric Hodgkin's disease: long‐term follow‐up demonstrates equivalent survival rates following different management schemes
4. Intensive chemotherapy and low‐dose radiotherapy for the treatment of advanced‐stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group Study
5. Efficacy and toxicity of multiagent (COP/ABVD) chemotherapy and low‐dose involved‐field radiotherapy in pediatric Hodgkin's disease
6. Complications of treatment of Hodgkin's disease in children
7. Risk of second cancers after treatment for Hodgkin's disease
8. Increased risk of secondary acute nonlymphocytic leukemia after extended‐field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease
9. Gonadal function in Hodgkin's disease: long‐term follow‐up off chemotherapy
10. Female reproductive potential after treatment for Hodgkin's disease
11. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience
12. Severe bleomycin‐induced pneumonitis: clinical features and response to corticosteroids
13. Natural course of bleomycin‐induced pneumonitis: a follow‐up study
14. Long‐term side effects in irradiated patients with Hodgkin's disease
15. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function
16. Pulmonary toxicity after radiation and bleomycin: a review
17. Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer
18. Report of the committee on Hodgkin's disease staging classification
19. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide
20. Ventilatory function in normal children and young adults—Mexican Americans, White and Black: I. Spirometry
21. Respiratory function tests
22. Spirometric standards for healthy non‐smoking adults
23. Standards of pulmonary function in children
24. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state
25. A mixed linear model with linear covariance structure: a sensitivity analysis of maximum likelihood estimators
26. Lung volumes
27. Pediatric Hodgkin's disease: pulmonary, cardiac and thyroid function following combined modality therapy
28. Role of single‐breath carbon monoxide‐diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients
29. Pulmonary morbidity 10‐18 years after irradiation for Hodgkin's disease
30. Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease
31. Bleomycin‐induced changes in the carbon monoxide transfer factor of the lung and its components